Comparative in vitro antimicrobial activity of the newly synthesized quinolones WQ-3034 and HSR-903 and other quinolones against Mycobacterium tuberculosis and Mycobacterium avium complex

Japanese Journal of Chemotherapy

Volumn 48, Issue 12, 2000, Pages 892-897

  Ogasawara, K ^a   Sato, K ^a   Tomioka, H ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

In vitro; Mycobacterium avium complex

Indexed keywords

1 (6 AMINO 3,5 DIFLUORO 2 PYRIDYL) 8 CHLORO 6 FLUORO 1,4 DIHYDRO 7 (3 HYDROXY 1 AZETIDINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; 5 AMINO 7 (7 AMINO 5 AZASPIRO[2.4]HEPT 5 YL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHYL 4 OXO 3 QUINOLINECARBOXYLIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN; SITAFLOXACIN; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SYNTHESIS; IN VITRO STUDY; LUNG ALVEOLUS CELL; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 0034522491     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. New antimycobacterial agents
2. New drugs for tuberculosis
3. In-vitro activities of quinolones against mycobacteria
4. The clinical use of fiuoroquinolones for the treatment of mycobacterial diseases
5. Prospects for development of new antimycobacterial drugs
6. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin
7. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859 a
8. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis
9. In vitro studies with WQ-3034, a newly synthesized acidic fluoroquinolone
10. WQ-3034, a novel acidic fluoroquinolone: In vitro and in vivo antimicrobial activities
11. In vitro activity of HSR-903, a new quinolone
12. In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens
13. In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections
14. Coraparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex
15. Comparative in vitro activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859 a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex
16. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355)
17. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium from patients with acquired immune deficiency syndrome
18. Use of Mono Mac 6 human monocytic cell line in parallel antimycobacterial drug studies
19. Mycobacterium tuberculosis invades and replicates within type II alverolar cells